Life science companies are joining with the UK government to co-invest in new projects, under a plan seen as demonstrating the country remains an attractive place to invest despite Brexit.
The sector deal between the government and the industry unveiled on Wednesday was accompanied by an announcement that the pharma company GlaxoSmithKline (GSK) is invest £40 million in the whole genome sequencing of the 500,000 volunteers whose DNA and associated medical records are held in the UK Biobank.
Image: https://sciencebusiness.net
